u/vikram_mbeki
Contributes reviews on supplier material. Based in Vaasa.
member · joined 13 Apr 2025
Comments — page 2 of 5
comment on three years of glucagon threads, summarised so you do not have to read them in c/survodutide · 16 points · 17 days ago
hepatic fat and survodutide are the story
comment on [NHS] GP said no, specialist said yes, eighteen months apart in c/glp1uk · 46 points · 18 days ago
private 10mg is pharmacy in Denmark this month
comment on [Win] HSA dollars changed the real cost by a third and i nearly missed it in c/insurancefights · 35 points · 18 days ago
Copay was external review for the copay then another 9% of the total. Read the actual plan document.
comment on small win: pentadecapeptide stopped being a problem at week 15 in c/bpc157 · 9 points · 20 days ago
sequence and naming claims need the actual sequence
comment on [Data] packaging quality by vendor, scored on five things, 60 shipments in c/intlshipping · 1 points · 21 days ago
the reship outcome is data worth posting
comment on stopped losing at 1.7 so i went to 2.4 and lost nothing faster in c/semaglutide · 17 points · 23 days ago
the quiet is real. the food noise just stops.
comment on the sequence question that gets asked weekly, answered properly in c/bpc157 · 1 points · 24 days ago
pentadecapeptide is sequence, the supply chain naming is a mess
comment on reading pricing threads from 2024 and half of it aged badly in c/glp1uk · 2 points · 1 months ago
the tier 3 pathway is the only free route, it is slow
comment on someone explain plateau to me like I have not read a paper in years in c/semaglutide · 9 points · 1 months ago
week 79 on the pen, 20kg down, this is the answer
comment on what changed for me between week 5 and week 54 in c/compounding · 7 points · 1 months ago
I am going to push back on this slightly.
comment on glucagon — 17 things I got wrong before I got it right in c/survodutide · 69 points · 2 months ago
New Zealand here. Waited 9 months on a list, gave up, went private, and the total cost was roughly what I expected.
comment on pharmacology is the most under-discussed thing in c/glp1women in c/glp1science · 2 points · 2 months ago
receptor distribution matters, GLP-1 is not everywhere
comment on anyone else notice API source kicking in around week 89 in c/compounding · 30 points · 2 months ago
503B compounding is different from 503A, different rules, different legality
comment on am I the only one who found API source harder than the injections in c/compounding · 58 points · 2 months ago
Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.
comment on [Question] rodent data — what am I missing here in c/bpc157 · 45 points · 2 months ago
regulatory status changed in 19 countries, check yours
comment on UK — my 16-week log, condensed into one table in c/glp1uk · 55 points · 2 months ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on [Lab] 12th independent test on QSC, and the trend is the interesting part in c/semaglutide · 168 points · 3 months ago
Not to be pedantic but titration and Wegovy are being used interchangeably and they are not interchangeable in real life.
comment on small win: appeal stopped being a problem at week 5 in c/insurancefights · 39 points · 3 months ago
This is correct. Appeal letters work.
comment on Spain: Wegovy, and what it actually costs here in c/semaglutide · 3 points · 3 months ago
Ozempic versus Wegovy versus research grade is the wrong argument, they are literally the same molecule
comment on [Discussion] the incretin advice in here is 14 years out of date in c/glp1science · 13 points · 3 months ago
Sceptical. If this were true we would see it reflected in the data and we do not.